宣肺通窍方治疗小儿鼻源性慢性咳嗽的疗效观察  

Observation on the therapeutic efficacy of Xuanfei Tongqiao for pediatric rhinogenous chronic cough

作　　者：陈艳洋[1] 曾莺[1] 邓丽莎[1] 

机构地区：[1]广东省佛山市中医院,广东佛山528000

出　　处：《广东医学院学报》2016年第1期87-89,共3页Journal of Guangdong Medical College

基　　金：佛山市医学类科技攻关科目(No.2014AB00335)

摘　　要：目的观察宣肺通窍方治疗鼻源性慢性咳嗽的疗效。方法将60例确诊为鼻源性慢性咳嗽的患儿分为对照组和治疗组,每组30例。对照组予以氯雷他定片及氨溴索口服液口服,治疗组予以宣肺通窍方汤剂口服,疗程为2周。结果治疗组和对照组的咳嗽症状评分治疗前差异无统计学意义[(2.17±0.59)vs(2.13±0.57),P>0.05],治疗后差异有统计学意义[(0.33±0.66)vs(0.77±0.86),P<0.05]。治疗组的疗效优于对照组(P<0.05)。结论中药宣肺通窍方治疗鼻源性慢性咳嗽能快速缓解咳嗽症状,提高疗效。Objective To observe the therapeutic efficacy of Xuanfei Tongqiao for rhinogenous chronic cough. Methods 60 sick children with rhinogenous chronic cough were divided into Control Group and Treatment Group with 30 cases in each group. Control Group was administered with loratadine and ambroxol hydrochloride oral solution, while Treatment Group was orally administered with Xuanfei Tongqiao decoction. The treatment lasted for 2 weeks. Results There was no significant difference in cough symptom score between Control Group and Treatment Group before the treatment [（2.17 ± 0.59） vs（2.13 ±0.57）, P〉0.05], while there was statistical difference between the two groups after treatment [（0.33 ± 0.66） vs（0.77 ± 0.86）, P〈0.05]. The curative effect of Treatment Group was better than that of Control Group（P〈0.05）. Conclusion For the treatment of rhinogenous chronic cough, Xuanfei Tongqiao can quickly relieve the symptoms of cough and improve therapeutic efficacy.

关 键 词：宣肺通窍方 慢性咳嗽 儿童 

分 类 号：R725.6[医药卫生—儿科]